ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ACOR Acorda Therapeutics Inc

0.661
0.00 (0.00%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Acorda Therapeutics Inc ACOR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.661 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.661 0.661
more quote information »

Recent News

Date Time Source Heading
4/15/202416:03BWAcorda Therapeutics Announces Delisting from Nasdaq
4/03/202416:30BWAcorda Therapeutics Announces Nasdaq Delisting Notification
4/01/202417:35BWAcorda Therapeutics and Merz Announce Signing of “Stalking..
4/01/202415:01BWAcorda Cancels Q4 and Year End 2023 Earnings Conference Call..
3/25/202415:01BWAcorda Fourth Quarter/Year End 2023 Update:..
1/11/202407:33EDGAR2Form 8-K - Current report
1/11/202407:01BWAcorda Therapeutics to Regain Global Commercialization..
12/01/202315:30EDGAR2Form 8-K - Current report
11/13/202315:16EDGAR2Form 8-K - Current report
11/13/202315:01BWAcorda Therapeutics Reports Third Quarter 2023 Financial..
11/06/202315:01BWAcorda Third Quarter 2023 Update: Webcast/Conference Call..
11/06/202307:00BWAcorda Therapeutics Announces Biopas Laboratories Submission..
8/08/202315:12EDGAR2Form 8-K - Current report
8/08/202315:01BWAcorda Therapeutics Reports Second Quarter 2023 Financial..
8/02/202307:00BWAcorda Therapeutics Announces Launch of New INBRIJA®..
8/01/202307:00BWAcorda Second Quarter 2023 Update: Webcast/Conference Call..
6/28/202316:08BWTom Burns Elected to the Acorda Therapeutics Board of..
6/26/202307:23BWAcorda Therapeutics Regains Compliance with Nasdaq Minimum..
6/26/202307:00BWAcorda Therapeutics Regains Compliance with Nadaq Minimum..
6/02/202315:01BWAcorda Therapeutics Announces Completion of 1-for-20 Reverse..
5/31/202315:01BWAcorda Therapeutics to Conduct 1-for-20 Reverse Stock Split
5/30/202307:00BWAcorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual..
5/11/202315:01BWAcorda Therapeutics Reports First Quarter 2023 Financial..
5/10/202306:00BWAcorda Therapeutics to Make June 2023 $6.2 Million Interest..
5/08/202306:00BWAcorda Therapeutics and Chance Pharmaceuticals Announce..
5/04/202308:41BWAcorda First Quarter 2023 Update: Webcast/Conference Call..

Your Recent History

Delayed Upgrade Clock